inaki

About Iñaki Díaz

This author has not yet filled in any details.
So far Iñaki Díaz has created 17 blog entries.

Collaboration at the heart of VICT3R: highlights from the 4th Consortium Meeting

By |2026-03-06T09:56:47+02:00March 6th, 2026|

Collaboration lies at the heart of the VICT3R project. Bringing together data scientists, software and computer system validation experts, industry partners, and regulators is essential to tackle the complex challenge the project addresses: developing Virtual Control Groups (VCGs) that could one day replace concurrent control groups in animal studies. On 26–27 February 2026, the VICT3R consortium met in Barcelona for its 4th Consortium Meeting and

Vera Rogiers

By |2026-01-23T09:17:28+02:00January 23rd, 2026|

In our latest Minds Behind VICT3R , we’re featuring Prof. Emerita Vera Rogiers, member of the VICT3R Scientific and Regulatory Advisory Board (SRAB). Vera has spent her career advancing alternatives to animal testing, first as the leader of the In Vitro Toxicology and Dermato-Cosmetic Sciences group at the Vrije Universiteit Brussel and more recently on the regulatory side, advising the European Commission as co-chair of

Karolina Kopańska

By |2025-11-25T10:00:13+02:00November 25th, 2025|

In our latest Minds Behind VICT3R , we’re catching up with Karolina Kopańska  from CAATevents. Karolina co-Leads VICT3R WP8, dedicated to the retrospective and prospective testing supporting the qualification of the Virtual Control Group (VCG) concept. She also coordinates the VICT3R Regulatory Interaction Task Force (RITF), which drives VICT3R’s engagement with policymakers and regulators worldwide.

More Minds, More Impact − New Members Join the VICT3R Community

By |2025-10-16T08:02:05+02:00October 16th, 2025|

We are proud to announce the expansion of the VICT3R consortium with the addition of new beneficiaries joining the project and organisations joining the VICT3R Associated Contract Research Organisation (CRO) Network. This growing network of organisations strengthens our mission to transform the way safety is evaluated in drug and chemical development by reducing reliance on laboratory animals. The newly joined beneficiaries include first-line industry partners

VICT3R Holds 3rd Consortium Meeting in Barcelona

By |2025-10-07T08:38:55+02:00October 7th, 2025|

The VICT3R consortium met in Barcelona on 29–30 September 2025 for its 3rd Consortium Meeting and General Assembly, marking the successful close of the project’s first year. With 67 participants attending in-person and another 60 joining online, the event brought together nearly 130 partners and collaborators from academia, industry, small and medium-sized enterprises, and members of the project’s Scientific and Regulatory Advisory Board to reflect

VICT3R: Virtually Speaking Webinar Series – Conversations Driving Change in Safety Science

By |2025-08-25T17:04:22+02:00August 25th, 2025|

VICT3R launched the first edition of its Virtually Speaking webinar series in early 2025, bringing together experts to discuss key topics relevant to VICT3R, shaping the future of toxicology and safety science. The series, which ran from January to July, combined open webinars for the broader community with closed sessions for the consortium, where we explored how to apply the concepts directly to project work.

Heinz Schwerdtfeger

By |2025-08-14T15:23:10+02:00July 23rd, 2025|

In our latest Minds Behind VICT3R , we’re catching up with Heinz Schwerdtfeger from Syncwork Ag, who leads the project WP9. Heinz and his team are making sure that the tools developed in VICT3R are properly validated and meet Good Laboratory Practice (GLP) standards − using what’s known as Computer System Validation (CSV).

Nadège Le Roux

By |2025-06-22T10:33:13+02:00June 12th, 2025|

We’re excited to present the latest edition of Minds Behind VICT3R, featuring Nadège Le Roux (Bristol Myers Squibb) – expert in Regulatory Sciences and Policy and a key contributor to VICT3R’s regulatory strategy. With a strong background in regulatory science, Nadège brings valuable insight into how innovative methods like Virtual Control Groups (VCGs) can be integrated into future safety assessments.

Armelle Grevot

By |2025-06-23T10:48:46+02:00May 14th, 2025|

This time, Minds Behind VICT3R puts the focus on Armelle Grevot (Novartis) – veterinary pathologist and leader of WP4 in VICT3R. With 20+ years of experience in toxicologic pathology, Armelle is helping shape the future of safety science by integrating digital histopathology into Virtual Control Groups (VCGs).

VICT3R Featured in the ‘Lab of Tomorrow’ Video Series

By |2025-05-02T10:39:05+02:00May 2nd, 2025|

We are pleased to announce that the VICT3R project has been featured in the latest episode of the Lab of Tomorrow video interview series by Eurogroup for Animals. This initiative highlights scientists who are actively working to phase out the use of animals in the regulatory assessment of drugs and other chemicals. In this new episode, Ferran Sanz (Project Coordinator, Universitat Pompeu Fabra) and Thomas